Detalhe da pesquisa
1.
CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab.
Front Immunol
; 12: 794638, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34868084